Reduction of noise-induced hearing loss using L-NAC and salicylate in the chinchilla
Additionally, geographic bias may limit generalizability: a potential geographic bias exists, as a substantial proportion of the included trials were conducted in North America and Europe, limiting generalizability to underrepresented populations in Asia, Africa, and South America
Those with rheumatoid arthritis and other autoimmune diseases carry a higher risk of cardiovascular disease than those without these conditions
Research also suggests potential involvement in regulating cytokines such as IL-6 and pathways such as NF-B and MAPK
The most commonly prescribed GLP-1 agonist is semaglutide, which has gained popularity in recent years after the Food and Drug Administration (FDA) approved it for the treatment of diabetes in 2017 (under the brand name Ozempic), for the treatment of obesity in 2021 (under the brand name Wegovy), and for reducing cardiovascular disease risk in 2024 (Wegovy)
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy
![Literature Review] Reduced intestinal GLP-1+ cell numbers are associated with an inflammation-related epithelial](https://moonlight-paper-snapshot.s3.ap-northeast-2.amazonaws.com/arxiv/reduced-intestinal-glp-1-cell-numbers-are-associated-with-an-inflammation-related-epithelial-metabolic-signature-1.png)
